Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Net Cash Flow (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Net Cash Flow data on record, last reported at -$406000.0 in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 122.64% year-over-year to -$406000.0; the TTM value through Dec 2025 reached -$28.1 million, down 58.27%, while the annual FY2025 figure was -$28.1 million, 58.27% down from the prior year.
  • Net Cash Flow reached -$406000.0 in Q4 2025 per SGHT's latest filing, up from -$8.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $235.9 million in Q3 2021 and bottomed at -$22.1 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $1.5 million, with a median of -$10.8 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: skyrocketed 2749.4% in 2021, then tumbled 2390.44% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$10.8 million in 2021, then crashed by 37.37% to -$14.8 million in 2022, then surged by 57.0% to -$6.4 million in 2023, then soared by 128.14% to $1.8 million in 2024, then crashed by 122.64% to -$406000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$406000.0 in Q4 2025, -$8.9 million in Q3 2025, and -$7.3 million in Q2 2025.